T cell immunity ameliorates covid-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in syrian hamsters

HIGHLIGHTS

• who: Eszter Somogyi et al. from the Chang Gung University, Taiwan have published the research work: T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters, in the Journal: (JOURNAL)
• what: In this study, PolyPEPI-SCoV-2 was evaluated for T_cell immunogenicity and protective efficacy against COVID-19 in a hamster model of severe COVID-19 .
• how: The authors developed a novel approach for the selection of immunoprevalent SARS-CoV-2-derived T_cell epitopes using an in silico cohort of HLA-genotyped individuals with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.